Patents by Inventor Frank Jonathan Lee

Frank Jonathan Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230146256
    Abstract: The present disclosure provides an isolated or purified SARS-CoV-2 Receptor Binding Domain (RBD) polypeptide and cells for producing such a polypeptide, as well as compositions and methods thereof.
    Type: Application
    Filed: March 25, 2021
    Publication date: May 11, 2023
    Applicant: REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: Frank Jonathan LEE, Yushun WAN, Jian SHANG
  • Publication number: 20220324918
    Abstract: The present disclosure provides engineered SARS-CoV-2 spike ectodomain polypeptides and cells for producing such a polypeptide, as well as compositions and methods thereof.
    Type: Application
    Filed: March 29, 2022
    Publication date: October 13, 2022
    Applicant: REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: Frank Jonathan Lee, Yushun Wan
  • Publication number: 20220001006
    Abstract: The present disclosure provides virus like nanoparticles (VLPs), which are capable of displaying multiple copies of a SARS-CoV-2 antigen, for eliciting protective immunity against a SARS-CoV-2 infection, as well as polypeptides, compositions and methods thereof.
    Type: Application
    Filed: June 29, 2021
    Publication date: January 6, 2022
    Applicants: Regents of the University of Minnesota, New York Blood Center, Inc.
    Inventors: Frank Jonathan Lee, Qibin Geng, Jian Shang, Marc Jenkins, Sung-Wook Hong, Lanying Du, Wanbo Tai, Yushun Wan